Recent advances in the targeting of FLT3 in AML

>> YOUR LINK HERE: ___ http://youtube.com/watch?v=rjupsEYIDtY

There are now several novel drugs targeting the protein kinase FLT3 in patients with acute myeloid leukemia (AML). Here, Keith Pratz, MD, of Johns Hopkins Un...

Speaker: Keith Pratz, Event: ASH 2017, Format: Interview, Subject: Acute Myeloid Leukemia, Field: Treatment, Medicines: Midostaurin, remission, FLT3, targeted therapy, TKI, response rate, survival, novel therapy
#############################